Author  
Place of duty  
Title   Áߵ ÀÌ»óÀÇ ÈÄÈä¼± T¼¼Æ÷ ¸²ÇÁÁ¾°ú ¹Ì¸¸¼º B¼¼Æ÷ ¸²ÇÁÁ¾ÀÇ ÀÓ»ó»óÀÇ ºñ±³ ( Clinicopathologic Comparison of Intermediate or High Grede Peripheral T-Cell Lymphoma with Diffuse B-Cell Lymphoma )
Publicationinfo   1997 Jan; 029(01): 136-146.
Key_word   Peripheral T-cell lymphoma, Diffuse B-cell lymphoma, Intermediate or high grade, Survival
Full-Text  
Abstract   Purpose: Peripheral T-cell lymphoma(PTCL) derived from mature T cells forms morphologically diverse group of non-Hodgkins lymphomas and the clinicopathologic features remain to be debated. In order to elucidate the specific characteristics of PTCL, comparison with a group of diffuse B-cell lymphomas(DBCL) was done. Materials and Methods: Between Dec. 1989 and Feb. 1993, clinical data of 67 cases of intermediate or high grade NHL identified as T-cell or B-cell origin by immunophenotyping was reviewed. Results: There were 30 cases of PTCL and 37 cases of DBCL. PTCL had more advanced stage and B symptoms at diagnosis. Frequent sites of extranodal involvement were bone marrow, nasal cavity/paranasal sinus, and skin in PTCL and gastrointestinal tract in DBCL. Based on NCI Working Formulation, 40% of PTCL and 14% of DBCL were high grade. Patients with DBCL had a better 3-year overall survival rate(67% vs 47%), however, there was no difference in complete remission rate and disease-free survival rate between two groups with intensive treatment. A subgroup of PTCL patients who had died earlier was found to have more advanced stage and poor performance status. Conclusion: Although patients with PTCL had worse survival in advanced stage, the outcome of patients with PTCL who received intensive treatment was comparable to that of DBCL.
Àú ÀÚ   Á¤°æÇØ(Kyung Hae Jung),¿ìÀμ÷(In Sook Woo),ÀåÈï¹®(Heung Moon Chang),Çã´ë¼®(Dae Seog Heo),¹æ¿µÁÖ(Yung Jue Bang),±èö¿ì(Chul Woo Kim),¹Ú¼±¾ç(Seon Yang Park),±èº´±¹(Byoung Kook Kim),±è³ë°æ(Noe Kyeong Kim)